Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. V. Bielinskyi"'
Publikováno v:
Patologìâ, Vol 21, Iss 2, Pp 100-105 (2024)
Non-alcoholic fatty liver disease (NAFLD) or due modern nomenclature – metabolic dysfunction-associated steatotic liver disease (MASLD) and atrial fibrillation are interconnected health problems that require reassessment of treatment strategies to
Externí odkaz:
https://doaj.org/article/b8ee25f3016d45b2966671423278b6cc
Publikováno v:
Zaporožskij Medicinskij Žurnal, Vol 25, Iss 3, Pp 198-203 (2023)
The prevalence of nonalcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) has increased globally in recent years. According to recent studies, NAFLD and AF affect approximately 32 % and 0.51 % of the general population, respectively.
Externí odkaz:
https://doaj.org/article/36a89fe46f824061b258fad669acca3c
Autor:
V. N. Seredyuk, R. V. Denina, M. V. Bielinskyi, Z. S. Andriitsiv, Nestor Seredyuk, P. P. Zvonar
Publikováno v:
Art of Medicine. :69-80
Dyslipidemia is an important problem for family doctors, as it is a risk factor for the development of atherosclerotic cardiovascular diseases (ACVD). ACVD is the cause of more than 4 million deaths in Europe today. Women in this sad statistic are 2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c28d7990948b5441023bba72c6d2970
https://doi.org/10.21802/artm.2021.3.19.69
https://doi.org/10.21802/artm.2021.3.19.69